vs

Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Empire State Realty Trust, Inc. (ESRT). Click either name above to swap in a different company.

AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $190.3M, roughly 1.9× Empire State Realty Trust, Inc.). Empire State Realty Trust, Inc. runs the higher net margin — 1.6% vs -0.8%, a 2.3% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 5.7%). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs 0.2%).

AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.

Empire State Realty Trust is a leading real estate investment trust that owns, manages, and operates a portfolio of premium commercial, residential, and retail properties primarily in the New York City metropolitan area, including the iconic Empire State Building. It serves corporate tenants, retail partners, and residential occupants, focusing on sustainable property operations and long-term asset value growth.

ASIX vs ESRT — Head-to-Head

Bigger by revenue
ASIX
ASIX
1.9× larger
ASIX
$359.9M
$190.3M
ESRT
Growing faster (revenue YoY)
ASIX
ASIX
+3.7% gap
ASIX
9.4%
5.7%
ESRT
Higher net margin
ESRT
ESRT
2.3% more per $
ESRT
1.6%
-0.8%
ASIX
Faster 2-yr revenue CAGR
ASIX
ASIX
Annualised
ASIX
3.4%
0.2%
ESRT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ASIX
ASIX
ESRT
ESRT
Revenue
$359.9M
$190.3M
Net Profit
$-2.8M
$3.0M
Gross Margin
7.6%
Operating Margin
-0.7%
15.5%
Net Margin
-0.8%
1.6%
Revenue YoY
9.4%
5.7%
Net Profit YoY
-892.9%
-73.7%
EPS (diluted)
$-0.11
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASIX
ASIX
ESRT
ESRT
Q1 26
$190.3M
Q4 25
$359.9M
$199.2M
Q3 25
$374.5M
$197.7M
Q2 25
$410.0M
$191.3M
Q1 25
$377.8M
$180.1M
Q4 24
$329.1M
$197.6M
Q3 24
$398.2M
$199.6M
Q2 24
$453.5M
$189.5M
Net Profit
ASIX
ASIX
ESRT
ESRT
Q1 26
$3.0M
Q4 25
$-2.8M
$32.2M
Q3 25
$-2.6M
$13.6M
Q2 25
$31.4M
$11.4M
Q1 25
$23.3M
$15.8M
Q4 24
$352.0K
$18.8M
Q3 24
$22.3M
$22.8M
Q2 24
$38.9M
$28.6M
Gross Margin
ASIX
ASIX
ESRT
ESRT
Q1 26
Q4 25
7.6%
Q3 25
6.8%
Q2 25
14.3%
Q1 25
14.2%
Q4 24
3.4%
Q3 24
14.4%
Q2 24
17.9%
Operating Margin
ASIX
ASIX
ESRT
ESRT
Q1 26
15.5%
Q4 25
-0.7%
17.8%
Q3 25
-0.9%
19.9%
Q2 25
7.7%
18.4%
Q1 25
7.7%
14.3%
Q4 24
-3.9%
21.7%
Q3 24
7.5%
22.7%
Q2 24
11.5%
20.8%
Net Margin
ASIX
ASIX
ESRT
ESRT
Q1 26
1.6%
Q4 25
-0.8%
16.1%
Q3 25
-0.7%
6.9%
Q2 25
7.7%
6.0%
Q1 25
6.2%
8.8%
Q4 24
0.1%
9.5%
Q3 24
5.6%
11.4%
Q2 24
8.6%
15.1%
EPS (diluted)
ASIX
ASIX
ESRT
ESRT
Q1 26
$0.20
Q4 25
$-0.11
$0.11
Q3 25
$-0.10
$0.05
Q2 25
$1.15
$0.04
Q1 25
$0.86
$0.05
Q4 24
$0.02
$0.07
Q3 24
$0.82
$0.08
Q2 24
$1.43
$0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASIX
ASIX
ESRT
ESRT
Cash + ST InvestmentsLiquidity on hand
$19.8M
$68.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$815.2M
$1.8B
Total Assets
$1.7B
$4.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASIX
ASIX
ESRT
ESRT
Q1 26
$68.8M
Q4 25
$19.8M
$132.7M
Q3 25
$23.7M
$154.1M
Q2 25
$18.4M
$94.6M
Q1 25
$8.3M
$187.8M
Q4 24
$19.6M
$385.5M
Q3 24
$17.3M
$421.9M
Q2 24
$12.1M
$535.5M
Stockholders' Equity
ASIX
ASIX
ESRT
ESRT
Q1 26
$1.8B
Q4 25
$815.2M
$1.1B
Q3 25
$818.2M
$1.0B
Q2 25
$823.7M
$1.0B
Q1 25
$794.4M
$1.0B
Q4 24
$774.6M
$1.0B
Q3 24
$766.4M
$1.0B
Q2 24
$746.6M
$1.0B
Total Assets
ASIX
ASIX
ESRT
ESRT
Q1 26
$4.4B
Q4 25
$1.7B
$4.5B
Q3 25
$1.7B
$4.1B
Q2 25
$1.6B
$4.1B
Q1 25
$1.6B
$4.1B
Q4 24
$1.6B
$4.5B
Q3 24
$1.5B
$4.4B
Q2 24
$1.5B
$4.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASIX
ASIX
ESRT
ESRT
Operating Cash FlowLast quarter
$63.7M
Free Cash FlowOCF − Capex
$36.1M
FCF MarginFCF / Revenue
10.0%
Capex IntensityCapex / Revenue
7.7%
10.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$6.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASIX
ASIX
ESRT
ESRT
Q1 26
Q4 25
$63.7M
$249.1M
Q3 25
$26.6M
$105.3M
Q2 25
$21.1M
$26.7M
Q1 25
$11.4M
$83.1M
Q4 24
$64.2M
$260.9M
Q3 24
$57.3M
$102.8M
Q2 24
$50.2M
$37.1M
Free Cash Flow
ASIX
ASIX
ESRT
ESRT
Q1 26
Q4 25
$36.1M
$50.6M
Q3 25
$66.0K
$72.8M
Q2 25
$-7.2M
$-55.1M
Q1 25
$-22.6M
$41.1M
Q4 24
$29.8M
$88.0M
Q3 24
$26.8M
$-65.1M
Q2 24
$16.7M
$19.5M
FCF Margin
ASIX
ASIX
ESRT
ESRT
Q1 26
Q4 25
10.0%
25.4%
Q3 25
0.0%
36.8%
Q2 25
-1.7%
-28.8%
Q1 25
-6.0%
22.8%
Q4 24
9.1%
44.5%
Q3 24
6.7%
-32.6%
Q2 24
3.7%
10.3%
Capex Intensity
ASIX
ASIX
ESRT
ESRT
Q1 26
10.0%
Q4 25
7.7%
99.6%
Q3 25
7.1%
16.5%
Q2 25
6.9%
42.8%
Q1 25
9.0%
23.4%
Q4 24
10.4%
87.5%
Q3 24
7.7%
84.1%
Q2 24
7.4%
9.3%
Cash Conversion
ASIX
ASIX
ESRT
ESRT
Q1 26
Q4 25
7.74×
Q3 25
7.72×
Q2 25
0.67×
2.35×
Q1 25
0.49×
5.27×
Q4 24
182.29×
13.88×
Q3 24
2.57×
4.51×
Q2 24
1.29×
1.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASIX
ASIX

Plant Nutrients$140.0M39%
Chemical Intermediates$92.8M26%
Caprolactam$64.4M18%
Nylon Resins$62.8M17%

ESRT
ESRT

Rental revenue (1)$166.1M87%
Observatory revenue$18.5M10%
Other revenue and fees$4.1M2%
Lease termination fees$1.4M1%
Third-party management and other fees$277.0K0%

Related Comparisons